The National Committee for Quality Assurance says it is developing a new outcomes-based measurement tool aimed at more accurately assessing the care delivered to patients with heart disease and diabetes.
In a Tuesday news release, Washington-based NCQA, well-known for its performance measure set for health plans and for its patient-centered medical home program, said the tool will extract electronic health-record data to provide a more complete picture of how patients' risks of adverse outcomes are reduced, based on individualized treatment.
NCQA is co-developing the measurement tool, known as the Global Cardiovascular Risk Score, with Archimedes, a healthcare modeling and analytics firm headquartered in San Francisco. The project is funded by a grant from the Robert Wood Johnson Foundation.
Margaret O'Kane, NCQA's president, said the tool could eventually be adopted for use by the CMS and private payers.